Adjuvant chemotherapy provides a survival benefit for patients with HR+ mucinous breast cancer, a retrospective study suggests.

Related Keywords

New York , United States , Arya Mariam Roy , Astrazeneca , Roswell Park Comprehensive Cancer Center ,